Compare ConocoPhillips (COP) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Revolution Medicines Inc. Common Stock — how do they compare? ConocoPhillips trades at $134.1 (market cap $161.21B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: ConocoPhillips is far larger — about 4× Revolution Medicines Inc. Common Stock's market cap, and ConocoPhillips pays a 2.5% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ConocoPhillips for 79 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| COP | RVMD | |
|---|---|---|
Market Cap | $161.21B | $40.32B |
Volume | 6,058,403 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $141.22 | $221.15 |
52-Week Low | $85.66 | $47.50 |
Typical Hold Time | 79 Days | 0 Days |
Enterprise Value | $176.81B | $37.02B |
Dividend Yield | 2.5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $134.10, up 3.28% today, showing strong momentum with two consecutive quarterly earnings beats. The stock exhibits bullish technical signals with moving averages supporting upward trends. Fundamentally, the company maintains solid profitability with 14.65% net income margin and reasonable valuation at 17.75 P/E ratio. Recent developments include a 20-year LNG supply agreement with Venture Global and potential asset sales in Norway and UK operations.
Outlook remains positive with 75% analyst buy ratings and $154.75 consensus price target suggesting 15% upside. Key opportunities include energy market strength and strategic LNG expansion, while risks involve oil price volatility and geopolitical exposure in Middle East operations. The company's strong cash flow generation supports shareholder returns through dividends and buybacks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
